Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04504669 |
Title | First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | AstraZeneca |
Indications |
head and neck squamous cell carcinoma clear cell renal cell carcinoma |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | FRA | ESP | CAN |